Spiridon (Spirazidinum; list a) - antineoplastic. Applied intravenously (solution prepared immediately before use, introducing into the vial with the preparation of sterile izotoniceski solution of sodium chloride at the rate of 5 ml 0.01 g of spiritine) in laryngeal cancer 0.03 g 1 time in three days on the rate of 0.24-0.36 g; in malignant tumors of the nasopharynx to 0.01-0.02 g daily, at the rate of 0.25 0.28 g; in lung cancer on 0,02-0,04 g daily, at the rate of 0.2-0.4 g; with chlamydia 0.02 g daily, at the rate of 0.2, the Drug does not cause pronounced inhibitory action on the blood. Spirutein can be assigned with leukemia States and also in combination with x - ray-and radiotherapy.
The release form: the hermetically sealed vials containing 0.03 g of spiritine.
Cm. also Antitumor agents.